The International Market Analysis Research and Consulting Group is a leading adviser on management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, chemicals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and markets with close cooperation at all levels of the client organization. This ensures that our clients achieve unmatchable competitive advantage, build more proficient organizations, and secure lasting results.
The latest report by IMARC, titled “ Cell Isolation Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-20 28
” " the global cell isolation market reached a value of US$ 11.9 Billion in 2022.
Cell isolation is separating specific cells from a heterogeneous mixture of cells. The cells are generally labeled with fluorescent antibodies and then passed through a flow cytometer, which separates cells based on their fluorescent properties. This allows the cell isolation to be specific while isolating cells with high purity. Apart from this, density gradient centrifugation can also be used for cell isolation, which separates cells on the basis of their density, and microfluidics, while utilizing microscale channels and chambers to separate cells based on their size and shape.
Cell isolation is important in many applications, including stem cell research, cancer diagnosis and treatment, and tissue engineering. By isolating specific cells from a heterogeneous mixture, researchers can study their characteristics and behaviors in more detail and develop new therapies and treatments based on their findings.
Request Free Sample Report: https://www.imarcgroup.com/cell-isolation-market/requestsample
The global market is primarily driven by the increasing demand for cell-based therapies. In line with this, the heavy investments in regenerative medicine are significantly contributing to the market growth. Furthermore, the growing research activities in areas, such as cancer and immunology, are positively influencing the market. Apart from this, the rising prevalence of chronic diseases is catalyzing the market. Moreover, the escalating demand for personalized medicine is propelling the market. Besides, rapid technological advancements in cell isolation techniques and the development of automated cell isolation systems are expected to offer numerous opportunities for market expansion.
Additionally, the increasing investments in the healthcare sector worldwide are providing a boost to the market. Some of the other factors driving the market include the increasing prevalence of cancer and infectious diseases, the rising demand for biopharmaceuticals, and the easy availability of technologically advanced processes for this technique. On account of the factors above, the market is anticipated to reach a value of US$ 28.5 Billion by 2028, exhibiting a CAGR of 15.7% during 2023-2028.
Looking forward, the market value is projected to reach a strong growth during the forecast period (2023-2028).
Market Summary:
Breakup by Technique:
• Centrifugation
• Surface Marker
• Filtration
Breakup by Cell Type:
• Human Cells
• Animal Cells
Breakup by Product:
• Consumables
• Reagents, Kits, Media and Sera
• Beads
• Disposables
• Instruments
• Centrifuges
• Flow Cytometers
• Filtration Systems
• Magnetic-activated Cell Separator Systems
Breakup by Application:
• Biomolecule Isolation
• Therapeutics
• Stem Cell Research
• Cancer Research
• Tissue Regeneration
• In-Vitro Diagnostics
Breakup by End Use:
• Biotechnology and Biopharmaceutical Companies
• Hospitals and Diagnostic Laboratories
• Research Laboratories and Institutes
• Others
Breakup by Region:
• North America
• United States
• Canada
• Asia-Pacific
• China
• Japan
• India
• South Korea
• Australia
• Indonesia
• Others
• Europe
• Germany
• France
• United Kingdom
• Italy
• Spain
• Russia
• Others
• Latin America
• Brazil
• Mexico
• Others
• Middle East and Africa
Competitive Landscape with Key Players:
• Alfa Laval AB
• Becton Dickinson and Company
• Beckman Coulter Inc. (Danaher Corporation)
• Bio-Rad Laboratories Inc.
• General Electric Company
• Merck KGaA
• Miltenyi Biotec B.V. & Co. KG
• pluriSelect Life Science UG (haftungsbeschränkt) & Co. KG
• Roche Holding AG
• STEMCELL Technologies Inc.
• Terumo Corporation
• Thermo Fisher Scientific Inc.
View Full Report with TOC & List of Figure: https://www.imarcgroup.com/cell-isolation-market
We are the trusted business partners to the world's leading corporates, governments, and institutions
We are the trusted business partners to the world's leading corporates, governments, and institutions
© 2019 IMARC All Rights Reserved
This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of International Market Analysis Research and Consulting (IMARC). No part of this publication may be reproduced, repackaged, redistributed or resold in whole or in any part. The publication may also not be used in any form or by and means graphic electronic or mechanical, including photocopying, recording, taping or by information storage or retrieval, or by any other form, without the express consent of International Market Analysis Research and Consulting (IMARC).
Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have been based on information and sources believed to be accurate and reliable at the time of publishing. International Market Analysis Research and Consulting makes no representation of warranty of any kind as to the accuracy or completeness of any Information provided. IMARC accepts no liability whatsoever for any loss or damage resulting from opinion, errors or inaccuracies if any found this publication.
IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International Market Analysis Research and Consulting. All other trademarks used in this publication are registered trademarks of their respective companies.
